Introduction
A functioning acid-base balance results in normal blood pH and is critical for regular cellular and organ function 1, 2 . Next to the kidney and lungs, the liver is now recognized as an important acid-base regulation organ 3 , playing a crucial role in various homeostatic pathways, such as the metabolism of organic acid anions like lactate and certain amino acids 4 . Consequently, patients with liver dysfunction often show acid-base disorders. Interestingly, the literature on acid-base disorders in liver disease is very limited. In addition, standard acidbase variables frequently fail to unmask the underlying acid-base disorders in liver disease 5, 6 .
In contrast to the traditional model of acid-base equilibrium based on the HendersonHasselbalch-formula 7, 8 , the more recent physical-chemical approach (also known as Stewart's approach) 9 provides a better understanding of the underlying mechanisms of acidbase disorders in liver disease. The most common acid-base disturbance in patients with liver disease is respiratory alkalosis; however, various complex metabolic disorders of acid-base equilibrium also occur in patients with both stable and decompensated cirrhosis 10 .This review will thus focus on the pathophysiological role of the liver in acid-base disorders that result from liver injury in the setting of cirrhosis, critical illness and acute liver failure; it will also cover diagnostic approaches as well as specific therapeutic interventions in order to optimize patient management.
The physiological role of the healthy liver in acid-base regulation (Figure-1) Lactate metabolism and the Cori Cycle
Lactic acidosis is the most important type of metabolic acidosis in intensive care patients. It results from tissue hypoxia secondary to circulatory failure 11, 12 , reduced lactate removal due to sympathoadrenal-induced vasoconstriction and reduced blood flow to the liver, kidney and resting muscles 13 . Lactate is also produced in the working muscle during anaerobic glucose utilization. The healthy liver acts as the main consumer of lactate and contributes to 30-70% of lactate metabolism 14, 15 . Experimental data indicated that liver lactate consumption is directly related to arterial lactate concentrations 16 , rather than liver blood flow 17 . Even after major hepatectomy with a 50% loss of functional liver tissue, blood lactate concentrations remain unchanged, underlining the functional reserve of a healthy liver to counterbalance lactic acidosis 18 . After hepatic uptake, lactate is first converted to pyruvate and then retransformed to glucose in a process called gluconeogenesis. Together, the release of lactate from the working muscle and its retransformation to glucose in the liver is called the Cori Cycle, and it releases equimolar amounts of HCO 3 -19 .
Albumin synthesis
In the physiological range of blood pH, albumin behaves as a weak acid. Hypoalbuminaemia due to decreased production (e.g., in liver disease or malnutrition) or increased loss (e.g., nephrotic syndrome, intestinal loss or large, chronic wounds) results in mild metabolic alkalosis. In contrast, hyperalbuminaemia, which can be seen in patients with severe dehydration but is rarely observed, contributes to mild metabolic acidosis 20, 21 .
Ketogenesis and ketoacidosis
Keto acids are produced in the mitochondria of the liver when carbohydrate or fat is incompletely oxidized. Keto acids 3-hydroxybutyric acid and acetoacetic acid dissociate at physiologic pH, resulting in increased H+ concentration, and may ultimately lead to ketoacidosis. Therefore, the net production of keto acids as well as their urinary excretion is controlled by a feedback mechanism, leading to reduced endogenous acid production if pH decreases 22 and increased keto acid production if pH rises 23 . This rapid up-or downregulation applies both to hepatic ketogenesis as well as lactate production. It can be sustained and it reverses completely as an acid-base challenge disappears 24 . Hepatic ketogenesis and its regulation are negligible and do not cause relevant acidosis under normal conditions. However, as a consequence of starvation or massive alcohol consumption, ketogenesis with substantial metabolic acidosis can occur.
Urea production
The neurotoxic weak acid NH 4 arises during protein breakdown, with a daily amount of approximately 1 mol NH 4 based on an average protein intake of 100 g per day 25 . In the liver, NH 4 is further processed to urea, which can be excreted via urine. The process of urea production consumes equal amounts of the strong base HCO 3 -6 . Therefore, urea production is not only a detoxification process; it may also play a role in acid-base regulation 26 . Indeed, early studies suggested that the liver has a direct acid-base regulation effect by altering ureagenesis and therefore HCO 3 -consumption 5, 25 . However, these results could not be reproduced in other studies [27] [28] [29] [30] [31] . Furthermore, ureagenesis, an acidifying process, increased rather than decreased in experimental human acidosis 32 . Boon et al. 33, 34 showed that the reduction of urea synthesis in acute and chronic acidosis was due to a marked decrease of hepatic amino acid transport and uptake rather than due to a change in the activity of the ornithine cycle per se. In summary, ureagenesis has no discernible homeostatic effect on acid-base equilibrium in humans. (ii) Loss and retention of HCO .
While BE Natrium -and BE Chloride -deviations are clinically important, changes in the plasma levels of inorganic phosphate (Pi), potassium (K), magnesium (Mg) and calcium (Ca) do not play an essential role; their serum levels are too low to have a significant impact on BE 37, 38 . 
Acid-base disorders in liver disease
Considering the various physiologic functions of the liver, it seems obvious that advanced chronic liver disease can result in a variety of acid-base disorders 2 . Furthermore, extrahepatic organ dysfunction in liver cirrhosis (e.g., encephalopathy, renal dysfunction) may also cause or aggravate acid-base disorders 39 . However, several studies using standard techniques for determining metabolic or respiratory acid-base disturbances, including pHvalue, HCO 3 -and standard base excess, could not detect significant metabolic acid-base abnormalities in liver disease 30, 31, 37 . In contrast, analyses performed using a physicalchemical approach (as described above) 9,38 revealed several underlying acidifying and alkalinizing metabolic acid-base disorders 37 . These acidifying and alkalinizing factors will be discussed. While the treatment of extrahepatic conditions (e.g., hepatorenal syndrome) is not a focus of this review, specific therapeutic interventions to stabilize acid-base homeostasis will be outlined.
Alkalinizing factors in patients with liver cirrhosis (Figure-3)
Even though several studies using standard techniques for evaluating acid-base equilibrium could not find any metabolic acid-base disorders, they reported the most well-established acid-base disorder in chronic liver disease, respiratory alkalosis 30, 31, [40] [41] [42] , with a more pronounced hypocapnia in patients with severe liver disease or viral hepatitis 37, 43, 44 . While the reason for this commonly observed respiratory acid-base disorder is not ultimately clear, there are several theories and underlying conditions leading to dyspnoea and compensatory hyperventilation 45, 46 . While massive ascites and/or hepatic hydrothorax 47 cause hypoxemia and thus hyperventilation, hyperammonaemia and hepatic encephalopathy 48 induce hyperventilation per se. A study by Lustik et al. 49 showed a correlation between increased progesterone and oestradiol levels (caused by impaired hepatic metabolism in advanced liver disease) that may directly stimulate ventilation by the activation of progesterone receptors in the central nervous system. Furthermore, dyspnoea can be aggravated in the case of hepatopulmonary syndrome or portopulmonary hypertension 46, 50, 51 ( Figure-3 ).
Figure-3: Mechanisms of hyperventilation and respiratory alkalosis in liver disease
Some studies from the 1980s reported overt metabolic alkalosis in patients with stable chronic liver disease. It was hypothesized that decreased hepatic urea cycle enzyme activity results in reduced bicarbonate elimination and thus metabolic alkalosis 5, 6, 25 . However, this theory was challenged as metabolic alkalosis was not actually observed in any other cirrhotic patient populations 29-31,37,52 unless patients were treated with diuretics, had taken antacids, or showed secondary hyperaldosteronism or low potassium levels 42, 53 . Furthermore, the decrease in urea cycle enzyme activities seems to result from reduced hepatic amino acid uptake in acute and chronic acidosis rather than from downregulated enzyme activity 33, 34 .
A physical-chemical acid-base analysis 37 revealed that hypoalbuminemic alkalosis is the main alkalinizing metabolic disorder in cirrhotic patients. As albumin is a weak acid, a decrease in albumin levels by 1 g/dL is followed by an approximate base excess increase by 3.7 meq/L 20, 54 , which explains the fact that BE Albumin increases with more severe liver disease 37 . However, hypoalbuminaemia may be already present in the early stages of liver cirrhosis as a result of diminished protein intake, increased protein requirements and altered protein and amino acid metabolism 55 . Therefore, it can be postulated that hypoalbuminaemia represents a major alkalinizing factor that is present in a large majority of cirrhotic patients 44 ;
hypoalbuminaemia has also been shown to be a common reason for metabolic alkalosis in critically ill patients 37, 56 .
Acidifying factors in patients with liver cirrhosis (Figure-4)
In compensated liver cirrhosis, the abovementioned alkalinizing acid-base disorders are partially balanced by several counteracting acidifying disorders that are discussed in this section 37 .
Hyponatraemia is a common finding in cirrhosis 57, 58 and almost 50% of ascites patients present with serum sodium levels below the physiological range 59 . Hyponatraemia in cirrhosis is a phenomenon caused by portal hypertension-induced systemic and especially splanchnic vasodilation, resulting in a relative decrease of effective circulating blood volume.
To compensate for this arterial "underfilling", water and sodium retention occurs through activation of the renin-angiotensin-aldosterone system (RAAS), non-osmotic, anti-diuretichormone (ADH)-release followed by tubular water reabsorption and the activation of the sympathetic nervous system 57, 58, 60, 61 . As a consequence, this hypervolemia results in dilution hyponatraemia.
Therefore, dilution with free water (pH = 7.00) plays a role in hyponatremia and has an acidifying effect on plasma (pH~7.40) 37, 44 . Furthermore, hyponatraemia is often aggravated by repeated paracentesis (which temporarily activates water-retention mechanisms during post-paracentesis circulatory dysfunction when sufficient volume expansion is not achieved)
in patients with decompensated cirrhosis 62 .
Hyperchloremic acidosis is another acidifying disorder that is frequently observed in cirrhosis as well as in critically ill patients 63 .
In general this acid-base disorder is characterized by replacement of bicarbonate with chloride due to various mechanisms 64 . In stable cirrhosis, hyperchloremic acidosis might be considered a compensation for chronic respiratory alkalosis. In acute respiratory alkalosis, the compensatory mechanism is based on alkaline titration of body's non-bicarbonate buffers 65 , with plasma proteins and inorganic phosphate (Pi) being the most important ones 38 . These mechanisms occur within approximately 5-10 minutes but have limited compensatory potential 65 . In chronic respiratory alkalosis, the kidney reacts and reduces acid excretion by lowering tubular hydrogen ion secretion, which can be observed by a reduction in ammonium excretion. Furthermore, bicarbonate excretion is increased and a new steady state develops as the kidney chronically suppresses bicarbonate reabsorption in return for an increased chloride reabsorption, resulting in hyperchloremic acidosis (quantified by a negative BE Chloride .) This adaptation takes approximately two to three days but has a high compensatory potential [65] [66] [67] [68] . . However, these defects were more common in patients with PBC. In addition, missing urine acidification is often linked to spironolactone-treatment, as hypoaldosteronism is associated with increasing serum potassium blocking NH 3 -production and promoting metabolic acidosis 70 (known as RTA Type IV). Furthermore, hyperchloremic acidosis is a potential limitation for the administration of large volume saline. It is an ongoing debate whether saline-induced hyperchloremic acidosis also leads to unfavourable clinical outcomes 74, 75 .
In compensated cirrhotic patients, metabolic acid-base disorders based on lactate or unmeasured anions (UMA) only play a minor role. However, these unmeasured anions, such as ketone bodies, and lactate may become important in critically ill cirrhotics 37, 42 and will be reviewed later. 
Balance of acidifying and alkalinizing acid-base factors in stable cirrhosis
As shown in Figure-5A , several offsetting acidifying and alkalinizing metabolic factors can be observed in stable chronic liver disease, leaving the overall BE and pH unchanged. It is unknown whether this balance is a consequence of successful physiologic acid-base regulation to avoid overt acidosis and alkalosis, or if it is a coincidental finding. . From an acid-base point of view, in a study of 181 critically ill cirrhotic patients, 39% of patients presented with acidaemia and 27% with alkalaemia at the time of ICU admission. In those patients, the overall BE was substantially decreased and the metabolic acid-base disorders due to hypoalbuminaemia, hyperchloraemia, elevated lactate and unmeasured anions were also profoundly different from what was observed in compensated cirrhotics 36, 37 . Therefore, unlike compensated patients, cirrhotic patients with critical illness showed net metabolic acidosis, owing to UMA, lactic acidosis and mild dilutional acidosis compensated by hypoalbuminemic alkalosis (Figure-5B ). Acute renal failure was associated with an even more negative BE and BE UMA . Acute renal failure and the presence of acidaemia and lactic acidosis were independently associated with increased ICU mortality 36 .
Acid-base status in critically ill patients with cirrhosis (
Lactic acidosis is a common finding in ICU patients 79 . Considerable progress has been made in understanding hyperlactataemia in sepsis, which is not only driven by an overproduction due to tissue hypoxia, dysfunction of the microcirculation 80 and increased glycolysis 81 but also by an underutilization due to impaired mitochondrial oxidation 79 . Furthermore, as 5 % of lactate is metabolized by the kidney, acute kidney injury (AKI) in the setting of critical illness can worsen hyperlactataemia 82 . While the healthy liver has a huge functional reserve of metabolizing lactate 18 , this lactate clearance is impaired in chronic liver diseases due to a decrease in the functional hepatocyte mass 83, 84 . Accordingly, when compared to liver-healthy subjects, fasting lactate levels were significantly elevated in patients with chronic liver diseases 82 . However, fasting lactate levels were still within the range of normal and lactate levels were not correlated with Child-Pugh score 37, 82 indicating no direct correlation with the severity of compensated liver disease. Nevertheless, liver function and lactate clearance are further compromised in the presence of acute illness 85, 86 . A dysfunctional liver may even become a net lactate producer in sepsis. While the splanchnic area was reported to be a major source of lactate production in septic patients with acute liver dysfunction 87 , others could not confirm these results and reported a net splanchnic lactate production in only 7% of septic patients 12 .
However, both studies were not performed in a population of cirrhotic patients 87, 88 . An experimental study (animal model of sepsis) showed that the liver can become a major site of acid production in early sepsis, as measured by the strong-ion difference 89 . Another study suggested, that the elevated lactate levels in patients with liver disease are a result of defects in hepatic pyruvate metabolism with a reduction in hepatic gluconeogenesis following severe hepatic necrosis 90 .
In conclusion, complex disturbances of lactate metabolism can be found in acute and chronic liver disease. More studies directly targeting this question are needed.
Complications in critically-ill cirrhotic patients with acidosis 36, [91] [92] [93] [94] [95] Complications:
• Development of acute on chronic liver failure (ACLF)
• Increased cardiac output / hyperdynamic circulation • Lower systemic vascular resistance values • More pronounced oxygen debt due to decreased oxygen extraction and impaired tissue perfusion • Blood volume sequestration in the splanchnic venous plexus due to splanchnic vasodilation followed by effective hypovolemia and RAAS activation leading to renal vasoconstriction and impaired renal function • More pronounced septic shock-associated hyperlactatemia • Adrenal insufficiency is common.
• Elevated unmeasured anions in patients with liver disease Adaptive mechanisms in cirrhotic patients: Adaptive mechanisms in liver-healthy subjects:
• Delayed / missing lactate clearance associated with prolonged acidemia • Susceptibility for extracellular edema, ascites and pulmonary edema -complicating fluid resuscitation and therefore restoring kidney function
• More rapid clearance / normalization of hyperlactatemia potentially improving lactic acidosis • More aggressive fluid resuscitation potentially improving UMA-acidosis . This drug was found to be safe in several settings, including septic patients 98 , patients with end-stage liver disease and cirrhotics undergoing orthotopic liver transplantation 97, 99 . While it significantly reduced lactate levels 52 , no survival benefit was observed with dichloroacetate treatment 100 .
Metformin-treatment in diabetic patients with liver cirrhosis was thought to be associated with an increased incidence of lactic acidosis 101 . However, a recent study showed that metformin therapy was not only safe in cirrhotic patients, but it also improved survival in diabetic patients with cirrhosis due to non-alcohol-steatohepatitis (NASH). However, this study mainly included Child-Pugh A-patients. Metformin should be used with caution in patients with Child-Pugh B and C cirrhosis 102 .
Acid-base disorders in acute liver failure (ALF; Figure-5C)
Most patients with acute liver failure (ALF) have substantially elevated lactate levels.
However, these changes were observed without acidaemia 35, 42, 103 . This contra-intuitive phenomenon was described as "stress hyperlactataemia" and it resulted from a massive increase in glycolysis caused by catecholamine-and other cytokine-mediated increases in cellular glucose uptake without hypoxia 104, 105 and a reduction in total body clearance 106 . In accordance, net local production of lactate in the absence of hypoxia was observed in the splanchnic area 107, 108 and the lungs in the setting of ALF 109 , after large burns 110 , in pulmonary injury 111 and in sepsis 112 . However, at physiological pH, lactic acid is almost completely dissociated to lactate -and protons (H + ) and should therefore cause metabolic acidosis 113, 114 . Accordingly, a study using the physical-chemical acid-base model 9 revealed offsetting metabolic acid-base disorders (Figure-5C ). Lactic acidosis was compensated by pronounced hypoalbuminemic alkalosis in patients with non-paracetamol-induced ALF, resulting in net respiratory alkalaemia due to hyperventilation 35, 103 . Another study reported an additional alkalinizing effect of hypochloraemia in patients with combined severe hepatic and renal failure 10 . While overt metabolic acidosis seems to be rare in non-paracetamol-induced ALF, there is conflicting data on patients with paracetamol-induced ALF. Record et al.
published a report on three severely acidotic patients presenting at 48 hours after paracetamol intoxication with high lactate levels; the patients presented without clinical signs of liver failure, but with an obvious failure of gluconeogenesis 103 . Importantly, most ALFpatients present with a stable overall acid-base state. Whether the presence of these offsetting acid-base disorders is a coincidence or if the hypoalbuminaemia is a result of hyperlactatemia remains unclear 35 . However, we believe that these beneficial disorders -in terms of acid-base balance -are a result of ALF and do not represent a regulatory mechanism. It is of clinical importance to consider that correction of hypoalbuminaemia by exogenous albumin infusions might lead to net metabolic acidaemia, as observed in severely sick patients with hepatic and renal failure 10 . However, the acidifying effect of 1 g/kg bodyweight 20% albumin solution infused in patients with intact liver function was statistically significant, but still very small due to the buffered drug formulation 115 . Therefore, the finding of albumin infusion-induced net metabolic acidaemia, as described above, might also be explained by an increase in UMA due to the high prevalence of coexisting renal failure in this (B) Net metabolic acidosis in critically ill cirrhotic patients; (C) Hypoalbuminemic alkalosis "neutralizes" lactic acidosis in acute liver failure. Table- 2)
Therapeutic implications (
The monitoring of acid-base status using the simplified physical-chemical model in patients with cirrhosis has several potential therapeutic consequences and is summarized in Table- 2.
While specific treatment of the underlying disease is the only intervention with a proven benefit on mortality (e.g., bleeding control, antibiotic treatment in the setting of sepsis), several supportive therapies have the potential to improve patient management 11, 116, 117 . In mechanically ventilated patients with cirrhosis and acidemia due to metabolic acidosis, hyperventilation mitigates the severity of acidemia. Based on physiologic considerations the targeted decrease in paCO 2 from 40 mmHg (∆paCO 2 ) should equal the observed decrease in standard base excess (∆SBE) 118 . E.g. in a patient with a SBE of -10 mmol/L the target paCO 2 is 30 mmHg (subtracting 10 from the normal paCO 2 of 40 mmHg). Table- 
Conclusions and outlook
In healthy individuals, the most important hepatic contributions to a stable acid-base state are lactate clearance and albumin production, while hepatic ureagenesis does not represent a relevant acid-base regulating mechanism. Patients with stable liver cirrhosis show an equilibrium of acidifying and alkalinizing metabolic acid-base disorders, resulting in a normal overall BE and pH. However, during hepatic decompensation or critical illness, this equilibrium may be rapidly destabilized, most often resulting in overt metabolic acidosis. Importantly, a normal pH and BE do not exclude underlying metabolic acid-base disorders in patients with liver disease.
Therefore, the physical-chemical model of acid-base evaluation, which considers the acid-base effects of albumin and electrolytes, should be applied to understand and properly treat the underlying disorders in patients with acute and chronic liver disease. Hypoalbuminemic alkalosis "neutralizes" lactic acidosis in acute liver failure.
BE Albumin : Base excess due to the alkalinizing effect of hypoalbuminaemia; BE UMA :
Base excess due to the acidifying effect of unmeasured anions (e.g., keto acids); BE Natrium : Base excess due to the acidifying effect of plasma dilution by free water; BE Chloride : Base excess due to the acidifying effect of hyperchloraemia; BE Lactate : Base excess due to the acidifying effect of elevated lactate. 
